Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lock

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 27, 2007
A prospective evaluation of helical tomotherapyGlenn Bauman, Slav Yartsev, George Rodrigues, et al.
The Lancet. Oncology|September 4, 2025
Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trialTamim Niazi, Fred Saad, Steven Tisseverasinghe, et al.
Advances in Radiation Oncology|February 1, 2021
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of <sup>18</sup>F-DCFPyL PET/CT RestagingWei Liu, Katherine Zukotynski, Louise Emmett, et al.
Cancers|June 26, 2026
Determining Optimal Fractionation of Neoadjuvant Radiation in Low-Risk, Early-Stage Breast Cancer-Randomized SIGNAL Clinical TrialMelanie Spears, Michael Lock, Brian Yaremko, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2019
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or BrachytherapyWei Liu, Katherine Zukotynski, Louise Emmett, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2016
Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El TorWilbur H Chen, Mitchell B Cohen, Beth D Kirkpatrick, et al.
Vaccine|January 25, 2006
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challengeCyril Empig, Julie R Kenner, Marcel Perret-Gentil, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
Breast Cancer Research and Treatment|July 8, 2020
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patientsAdrienne E Borrie, Finnley A Rose, Yun-Hee Choi, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|February 27, 2007
A prospective evaluation of helical tomotherapyGlenn Bauman, Slav Yartsev, George Rodrigues, et al.
The Lancet. Oncology|September 4, 2025
Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trialTamim Niazi, Fred Saad, Steven Tisseverasinghe, et al.
Advances in Radiation Oncology|February 1, 2021
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of <sup>18</sup>F-DCFPyL PET/CT RestagingWei Liu, Katherine Zukotynski, Louise Emmett, et al.
Cancers|June 26, 2026
Determining Optimal Fractionation of Neoadjuvant Radiation in Low-Risk, Early-Stage Breast Cancer-Randomized SIGNAL Clinical TrialMelanie Spears, Michael Lock, Brian Yaremko, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2019
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or BrachytherapyWei Liu, Katherine Zukotynski, Louise Emmett, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2016
Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El TorWilbur H Chen, Mitchell B Cohen, Beth D Kirkpatrick, et al.
Vaccine|January 25, 2006
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challengeCyril Empig, Julie R Kenner, Marcel Perret-Gentil, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
Breast Cancer Research and Treatment|July 8, 2020
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patientsAdrienne E Borrie, Finnley A Rose, Yun-Hee Choi, et al.
Pageof 17